The Centers for Medicare & Medicaid Services' proposed rule requiring TV ads for prescription drugs to disclose their list price has several significant fault lines, lawyers told the Pink Sheet, suggesting the reg may not hold up to challenges.
First and foremost is the question of whether the regulation violates the First Amendment by imposing an impermissible restriction on...